Over-all, these outcomes point out that incubation with human hepatocyte is a suitable predictive design with the metabolism of nitazenes in humans. In the previous report, human hepatocyte incubations also presented good effects when compared with in vivo with the prediction from the metabolism of etonitazepipne, an N-pyrrolidino analogue (Berardinelli https://directory-broker.com/listings12890293/the-fact-about-protonitazene-for-sale-in-europe-that-no-one-is-suggesting